What Spironolactone Does

Spironolactone is a medication that blocks aldosterone, a hormone that tells your kidneys to hold onto sodium and water. By stopping that signal, spironolactone causes your body to shed extra fluid and sodium through urine, which lowers blood pressure. It also preserves potassium instead of letting your kidneys flush it away—the reason it's called a "potassium-sparing" diuretic.

The drug was first approved by the FDA in 1959 for treating high blood pressure and fluid buildup in people with heart failure or liver disease. Over the past two decades, research has found other uses: dermatologists prescribe it for acne driven by androgens (male hormones), and some cardiologists use it in heart failure at doses lower than those needed to lower blood pressure. The mechanism is the same—blocking aldosterone—but the dose and the reason for prescribing differ.

Spironolactone is a prescription medication. A doctor must weigh the benefits against the risks for your specific situation, because the drug can raise potassium to dangerous levels in people with kidney disease or those taking certain other medications. This guide explains how the drug works, what the evidence shows, and what questions remain open—not a substitute for a conversation with your prescriber.

Key Takeaways

  • Spironolactone lowers blood pressure by blocking aldosterone, a hormone that makes kidneys retain sodium and water; it is one of several diuretics available and is chosen when potassium preservation matters.
  • In heart failure, low-dose spironolactone has been shown in randomized trials to reduce hospitalizations and death, separate from its blood-pressure effect.
  • For acne, spironolactone works by reducing androgen activity in the skin; evidence comes mainly from observational studies and small trials, not large randomized comparisons.
  • The main safety concern is hyperkalemia (high potassium), which becomes more likely in people with reduced kidney function or those taking ACE inhibitors, ARBs, or NSAIDs.
  • Spironolactone is not a first-line treatment for high blood pressure alone; it is usually added when other drugs are not working or when a specific reason (heart failure, acne, hormonal imbalance) points to it.

How Spironolactone Lowers Blood Pressure

Your kidneys filter waste and water from your blood and decide how much to keep and how much to excrete. Aldosterone, a hormone made by your adrenal glands, tells the kidney tubules to reabsorb sodium. Water follows sodium osmotically, so more sodium reabsorption means more fluid stays in your bloodstream. More blood volume pushes harder against vessel walls, raising pressure.

Spironolactone binds to aldosterone receptors in the kidney and blocks the hormone's signal. The result: your kidneys excrete more sodium and water, blood volume drops, and blood pressure falls. This process takes days to weeks—the drug does not work when ready. A typical starting dose for blood pressure is 12.5 to 25 mg once daily, though some people need higher doses.

Because spironolactone blocks the same aldosterone signal that normally causes potassium excretion, potassium levels rise. This is why it is called potassium-sparing. For people on other diuretics (like furosemide) that cause potassium loss, spironolactone can balance that out. For people with normal kidney function and no other risk factors, the rise is usually modest and manageable. For people with kidney disease or on medications that raise potassium, the risk is real.

Spironolactone in Heart Failure: The Strongest Evidence

The most robust evidence for spironolactone comes from heart failure research. In 1999, the RALES trial (Randomized Aldactone Evaluation Study) enrolled over 1,600 people with severe heart failure and found that low-dose spironolactone (12.5 to 25 mg daily) reduced death by 30% and hospitalizations by 35% over two years, compared to placebo. Participants were already on standard heart failure drugs (ACE inhibitors, diuretics, digoxin). The benefit was separate from blood pressure lowering—it reflected aldosterone's direct effects on heart tissue.

Since RALES, multiple trials have confirmed that aldosterone blockade helps in heart failure. The mechanism involves more than just fluid shedding: aldosterone promotes fibrosis (scarring) in the heart muscle and contributes to electrical instability. Blocking it slows these processes. Current heart failure guidelines recommend aldosterone antagonists (spironolactone or eplerenone, a similar drug) for people with reduced ejection fraction, especially those with symptoms despite ACE inhibitors and beta-blockers.

The doses used in heart failure trials are lower than those for blood pressure—usually 12.5 to 50 mg daily rather than 50 to 100 mg. This reflects a different goal: not maximum diuresis, but aldosterone blockade at a dose that minimizes hyperkalemia risk.

Spironolactone for Acne: What the Research Shows

Androgens (male hormones present in all bodies, but higher in some) stimulate sebaceous glands in the skin to produce more oil. In people prone to acne, excess sebum, bacteria, and dead skin cells clog pores. Spironolactone reduces androgen activity in skin cells by blocking androgen receptors and lowering androgen production. The result is less sebum, fewer clogged pores, and often clearer skin.

Evidence for spironolactone in acne comes mainly from observational studies and small open-label trials (where both doctor and patient know the treatment). A 2016 review in the Journal of Drugs in Dermatology found that doses of 50 to 200 mg daily improved acne in 50 to 90% of people studied, with the highest rates in women with acne that worsens before menstruation (a sign of androgen sensitivity). However, no large randomized controlled trial has compared spironolactone head-to-head against standard acne treatments like isotretinoin or oral antibiotics plus topical retinoids.

Dermatologists often prescribe spironolactone for acne in women and people assigned female at birth, particularly when acne is concentrated on the lower face and jawline (a pattern linked to androgens) or when it flares cyclically with the menstrual cycle. It is less commonly used in men, partly because of the risk of gynecomastia (breast tissue growth) at higher doses, though this is rare at acne-treatment doses.

Potassium Risk and Who Should Not Take It

Hyperkalemia—potassium above 5.5 mEq/L in blood—can cause irregular heartbeat and cardiac arrest. Spironolactone raises potassium in everyone, but the risk becomes serious in people with chronic kidney disease (where the kidneys cannot excrete potassium normally), those on ACE inhibitors or ARBs (which also raise potassium), or those taking NSAIDs like ibuprofen (which reduce kidney blood flow and potassium excretion).

Before starting spironolactone, your doctor will check your baseline potassium and kidney function (creatinine, eGFR). They will recheck potassium 1 to 2 weeks after starting and then periodically—how often depends on your risk profile. If you have an eGFR below 30 mL/min/1.73m² (severe kidney disease), spironolactone is usually avoided. If your eGFR is 30 to 60 (moderate disease), lower doses and closer monitoring are needed.

Other side effects are less common but worth knowing: spironolactone can cause breast tenderness or enlargement (gynecomastia) in men and people assigned male at birth, especially at higher doses or with longer use. Women may experience irregular periods or spotting. Some people report fatigue, headache, or dizziness. These usually resolve if the dose is lowered or the drug is stopped.

Spironolactone Versus Other Blood Pressure Drugs

For high blood pressure alone, spironolactone is not a first-line choice. ACE inhibitors, ARBs, calcium channel blockers, and thiazide diuretics have more evidence as starting drugs and are safer in a wider range of people. Spironolactone is added when blood pressure remains high despite one or more of these, or when a specific reason—heart failure, resistant hypertension, or hormonal imbalance—points to aldosterone blockade.

In resistant hypertension (blood pressure not controlled by three or more drugs), adding spironolactone often works. Studies show that people whose blood pressure does not respond to standard combinations often have elevated aldosterone levels, and blocking it can bring pressure down. A 2015 trial found that adding spironolactone to a three-drug regimen lowered systolic pressure by an average of 25 mmHg in people with resistant hypertension.

Compared to other potassium-sparing diuretics like amiloride or triamterene, spironolactone has the advantage of aldosterone blockade beyond just sodium and water shedding. Compared to loop diuretics like furosemide, it causes less potassium loss and is gentler on the kidneys in chronic use, though it works more slowly and is less powerful for acute fluid overload.

What Remains Uncertain

While spironolactone's mechanism is well understood and its benefits in heart failure are proven, several questions remain open. For acne, the lack of large randomized trials means we do not know how it compares to other hormonal treatments (like oral contraceptives) or to standard topical and oral antibiotics in head-to-head trials. Long-term safety data in acne treatment is limited—most studies follow people for 6 to 12 months, not years.

For blood pressure in people without heart failure, spironolactone's role is still being refined. Some research suggests that measuring aldosterone levels before starting might identify who will benefit most, but this is not standard practice. The optimal dose for different populations and the long-term cardiovascular outcomes (heart attack, stroke, death) compared to other drugs are areas where more evidence would help.

Spironolactone's effects in other conditions—polycystic ovary syndrome (PCOS), female pattern hair loss, and certain types of hypertension linked to primary aldosteronism—are areas of active research, but evidence is still preliminary and mostly observational.

Frequently Asked Questions

Can I take spironolactone if I have kidney disease?

It depends on how severe your kidney disease is. If your eGFR (a measure of kidney function) is above 60, spironolactone is usually safe with monitoring. If it is 30 to 60, lower doses and more frequent potassium checks are needed. If it is below 30, spironolactone is generally avoided because the risk of dangerous potassium levels is too high. Your doctor will check your kidney function before prescribing.

How long does it take for spironolactone to work?

For blood pressure, it usually takes 2 to 4 weeks to see the full effect. For acne, improvement is slower—most people see noticeable changes after 2 to 3 months, and the best results often take 4 to 6 months. In heart failure, the survival benefit appears over months to years, not weeks.

Can I take spironolactone with an ACE inhibitor or ARB?

Yes, but with caution and monitoring. ACE inhibitors and ARBs both raise potassium, and spironolactone does too, so the combination increases hyperkalemia risk. Your doctor will check potassium more frequently if you are on both. The combination is often used intentionally in heart failure because the benefits outweigh the risk when monitored carefully.

Does spironolactone cause weight loss?

Spironolactone causes fluid loss, which can show as a drop on the scale in the first week or two. This is not fat loss—it is water. Once your body adjusts, weight usually stabilizes. The drug does not increase metabolism or burn fat.

Is spironolactone safe during pregnancy?

Spironolactone is generally avoided in pregnancy, especially in the first trimester, because it crosses the placenta and animal studies have raised concerns about effects on fetal development. If you are pregnant or planning to become pregnant, tell your doctor before starting or continuing spironolactone. Other blood pressure drugs are preferred in pregnancy.